The $1.2 trillion pharma industry has ambitions for AI technology, but ‘people are ignoring’ a lot of its uses

For the pharmaceutical industry, which is staked out on the premise of finding, developing, and ultimately selling advanced new medications, there is no greater challenge than the sheer unpredictability of that task. Technology known as machine learning and artificial intelligence could change all that, its boosters say. That’s because in an industry with massive data…

Earnings Outlook: Biogen, Celgene, Bristol-Myers and AbbVie report earnings this week: Here’s what to expect

Celgene Corp., Bristol-Myers Squibb Co. and AbbVie Inc. are all reporting earnings later this week. These companies’ CELG, -0.16% BMY, +0.06% ABBV, +0.20%  second-quarter results are dropping during an uncertain time in the biopharmaceutical industry. Companies are facing several potential changes in health policy, including a proposal to shift the risk of Medicare Part D…

Tardigrades are now on the moon thanks to a crashed Israeli spacecraft – CNET

This isn’t a scientific representation of tardigrades in space. But they sure do look cool floating in orbit. Video screenshot by Bonnie Burton/CNET Tardigrades, affectionately known as water bears, are microscopic animals that can survive in almost any environment. We already know it’s possible for scientists to bring tardigrades back to life after a 30-year…

A top VC firm just got another $800 million to back healthcare and fintech startups. We talked to Oak HC/FT execs about what they’re looking to invest in next.

Oak HC/FT cofounder and managing partner Annie Lamont Oak HC/FT Venture capital firm Oak HC/FT just raised an $800 million fund, bringing its total assets under management to $1.9 billion. It’s the third fund for the firm, which was founded in 2014 and invests in healthcare and financial technology companies. We talked to Oak HC/FT…